These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10631955)

  • 1. Antigen presentation by parenchymal cells: a route to peripheral tolerance?
    Marelli-Berg FM; Lechler RI
    Immunol Rev; 1999 Dec; 172():297-314. PubMed ID: 10631955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CTLA-4 in the regulation and initiation of T-cell responses.
    Chambers CA; Krummel MF; Boitel B; Hurwitz A; Sullivan TJ; Fournier S; Cassell D; Brunner M; Allison JP
    Immunol Rev; 1996 Oct; 153():27-46. PubMed ID: 9010718
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4.
    Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
    J Immunol; 2001 Mar; 166(5):3107-13. PubMed ID: 11207262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for CTLA-4-mediated inhibitory signals in peripheral T cell tolerance?
    Allison JP; Chambers C; Hurwitz A; Sullivan T; Boitel B; Fournier S; Brunner M; Krummel M
    Novartis Found Symp; 1998; 215():92-8; discussion 98-102, 186-90. PubMed ID: 9760573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation.
    Chai JG; Vendetti S; Amofah E; Dyson J; Lechler R
    J Immunol; 2000 Sep; 165(6):3037-42. PubMed ID: 10975813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 and T cell activation.
    Oosterwegel MA; Greenwald RJ; Mandelbrot DA; Lorsbach RB; Sharpe AH
    Curr Opin Immunol; 1999 Jun; 11(3):294-300. PubMed ID: 10375557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New protein steals the show as 'costimulator' of T cells.
    Cohen J
    Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of CTLA-4 in the regulation of T cell immune responses.
    McCoy KD; Le Gros G
    Immunol Cell Biol; 1999 Feb; 77(1):1-10. PubMed ID: 10101680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement.
    Perez VL; Van Parijs L; Biuckians A; Zheng XX; Strom TB; Abbas AK
    Immunity; 1997 Apr; 6(4):411-7. PubMed ID: 9133420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of B7 costimulation in T-cell immunity.
    Harris NL; Ronchese F
    Immunol Cell Biol; 1999 Aug; 77(4):304-11. PubMed ID: 10457196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
    Linsley PS; Greene JL; Tan P; Bradshaw J; Ledbetter JA; Anasetti C; Damle NK
    J Exp Med; 1992 Dec; 176(6):1595-604. PubMed ID: 1334116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD28-B7 interactions are not required for intrathymic clonal deletion.
    Jones LA; Izon DJ; Nieland JD; Linsley PS; Kruisbeek AM
    Int Immunol; 1993 May; 5(5):503-12. PubMed ID: 7686392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of B7-dependent responses in CD28-deficient mice.
    Green JM; Noel PJ; Sperling AI; Walunas TL; Gray GS; Bluestone JA; Thompson CB
    Immunity; 1994 Sep; 1(6):501-8. PubMed ID: 7534617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New molecules on dendritic cells and their interactions with T lymphocytes.
    Hart DN; Starling GC; Egner W; Hock BD; McLellan AD; McKenzie JL; Williams LA; Simmons DL
    Adv Exp Med Biol; 1995; 378():351-4. PubMed ID: 8526091
    [No Abstract]   [Full Text] [Related]  

  • 17. Could expression of co-stimulatory molecules on B-PBL condition the acceptance or rejection of human liver grafts?
    Minguela A; Sánchez-Bueno F; Marín L; Miras M; Pons JA; Muro M; Torío A; García-Alonso AM; Robles R; Parrilla P; Ramirez P; Alvarez-López MR
    Transplant Proc; 2001; 33(1-2):1384-5. PubMed ID: 11267338
    [No Abstract]   [Full Text] [Related]  

  • 18. Blocking CD28/B7 with soluble competitors: immunological phenotype of mCTLA4-H gamma 1 transgenic mice.
    Lane P
    Res Immunol; 1995; 146(3):176-9. PubMed ID: 8525050
    [No Abstract]   [Full Text] [Related]  

  • 19. CTLA-4 is required for the induction of high dose oral tolerance.
    Samoilova EB; Horton JL; Zhang H; Khoury SJ; Weiner HL; Chen Y
    Int Immunol; 1998 Apr; 10(4):491-8. PubMed ID: 9620605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune response induced in vivo by dendritic cells is dependent on B7-1 or B7-2, but the inhibition of both signals does not lead to tolerance.
    Lespagnard L; Mettens P; De Smedt T; Bazin H; Urbain J; Leo O; Moser M
    Int Immunol; 1998 Mar; 10(3):295-304. PubMed ID: 9576617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.